Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Synthesis, Crystal Structure, Antibacterial and In Vitro Anticancer Activity of Novel Macroacyclic Schiff Bases and Their Cu (II) Complexes Derived from S -Methyl and S -Benzyl Dithiocarbazate
A series of novel macroacyclic Schiff base ligands and their Cu (II) complexes were synthesised via reacting dicarbonyls of varying chain lengths with
-methyl dithiocarbazate (SMDTC) and
-benzyl dithiocarbazate (SBDTC) followed by coordination with Cu (II) ions. X-ray crystal structures were obtained for compound
, an SBDTC-diacetyl analogue, and
, an SMDTC-hexanedione Cu (II) complex. Anticancer evaluation of the compounds showed that
, an SMDTC-glyoxal complex, demonstrated the highest cytotoxic activity against MCF-7 and MDA-MB-231 breast cancer cells with IC
values of 1.7 µM and 1.4 µM, respectively. There was no clear pattern observed between the effect of chain length and cytotoxic activity; however, SMDTC-derived analogues were more active than SBDTC-derived analogues against MDA-MB-231 cells. The antibacterial assay showed that
was the most susceptible bacteria to the compounds, followed by
. Compound
and the SMDTC-derived analogues
,
,
and
possessed the highest antibacterial activity. These active analogues were further assessed, whereby
possessed the highest antibacterial activity with an MIC of <24.4 µg/mL against
and
. Further antibacterial studies showed that at least compounds
and
were bactericidal. Thus,
and
were the most promising anticancer and antibacterial agents, respectively.